Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2019 | 1 |
2020 | 2 |
2021 | 1 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Prostate cancer recurrence in patients with negative or equivocal conventional imaging: A role for 18F-fluciclovine-PET/CT in delineating sites of recurrence and identifying patients with oligometastatic disease.
Urol Oncol. 2021 Jun;39(6):365.e9-365.e16. doi: 10.1016/j.urolonc.2020.10.017. Epub 2020 Nov 5.
Urol Oncol. 2021.
PMID: 33160848
Free PMC article.
18F-Fluciclovine Positron Emission Tomography in Men With Biochemical Recurrence of Prostate Cancer After Radical Prostatectomy and Planning to Undergo Salvage Radiation Therapy: Results from LOCATE.
Solanki AA, Savir-Baruch B, Liauw SL, Michalski J, Tward JD, Vapiwala N, Teoh EJ; LOCATE study group.
Solanki AA, et al.
Pract Radiat Oncol. 2020 Sep-Oct;10(5):354-362. doi: 10.1016/j.prro.2020.05.007. Epub 2020 May 25.
Pract Radiat Oncol. 2020.
PMID: 32464368
Item in Clipboard
The Impact of Positron Emission Tomography with 18F-Fluciclovine on the Treatment of Biochemical Recurrence of Prostate Cancer: Results from the LOCATE Trial.
Andriole GL, Kostakoglu L, Chau A, Duan F, Mahmood U, Mankoff DA, Schuster DM, Siegel BA; LOCATE Study Group.
Andriole GL, et al.
J Urol. 2019 Feb;201(2):322-331. doi: 10.1016/j.juro.2018.08.050.
J Urol. 2019.
PMID: 30179618
Free PMC article.
Clinical Trial.
Item in Clipboard
Cite
Cite